Full Press Release Details
Director Declaration
Pursuant to Listing Rule 9.6.14(2), PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ( PureTech or the Company ) notes that
Christopher Viehbacher, a Non-Executive Director and Chair of the Company s Board, has been appointed as President and Chief Executive Officer and a member of the Board of Biogen Inc. (Nasdaq: BIIB) with
effect from November 14, 2022.
For further information please contact:
Bharatt Chowrira, PhD, JD, President and Chief Business, Finance and Operating Officer, member of the Board of Directors and Company Secretary: +1 617 482 2333